These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical and genetic features of Chinese adult patients with tumour necrosis factor receptor-associated periodic fever syndrome. Zhao M; Luo Y; Wu D; Yang Y; Sun Y; Wang R; Shen M Rheumatology (Oxford); 2020 Aug; 59(8):1969-1974. PubMed ID: 31774538 [TBL] [Abstract][Full Text] [Related]
7. Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. Pelagatti MA; Meini A; Caorsi R; Cattalini M; Federici S; Zulian F; Calcagno G; Tommasini A; Bossi G; Sormani MP; Caroli F; Plebani A; Ceccherini I; Martini A; Gattorno M Arthritis Rheum; 2011 Apr; 63(4):1141-50. PubMed ID: 21225694 [TBL] [Abstract][Full Text] [Related]
8. A novel TNFRSF1 gene mutation in a Turkish family: a report of three cases. Cosan F; Yazici A; Yılmazer B; Gul A; Ustek D; Cefle A Clin Rheumatol; 2013 Mar; 32 Suppl 1():S83-5. PubMed ID: 20532935 [TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases. Kümpfel T; Hoffmann LA; Pellkofer H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P Neurology; 2008 Nov; 71(22):1812-20. PubMed ID: 19029521 [TBL] [Abstract][Full Text] [Related]
10. The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway. Greco E; Aita A; Galozzi P; Gava A; Sfriso P; Negm OH; Tighe P; Caso F; Navaglia F; Dazzo E; De Bortoli M; Rampazzo A; Obici L; Donadei S; Merlini G; Plebani M; Todd I; Basso D; Punzi L Arthritis Res Ther; 2015 Apr; 17(1):93. PubMed ID: 25888769 [TBL] [Abstract][Full Text] [Related]
11. Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases. Celebi-Tayfur A; Bilginer Y; Finetti M; Gattorno M; Ozen S Turk J Pediatr; 2013; 55(1):78-81. PubMed ID: 23692837 [TBL] [Abstract][Full Text] [Related]
12. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277 [TBL] [Abstract][Full Text] [Related]
13. A novel TNFRSF1A gene mutation in a patient with tumor necrosis factor receptor-associated periodic syndrome. Khabazi A; Maralani M; Andalib S; Sakhinia E Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):175-177. PubMed ID: 27793577 [TBL] [Abstract][Full Text] [Related]
14. Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis. Caminero A; Comabella M; Montalban X Clin Exp Immunol; 2011 Dec; 166(3):338-45. PubMed ID: 22059991 [TBL] [Abstract][Full Text] [Related]
15. Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Cantarini L; Lucherini OM; Brucato A; Barone L; Cumetti D; Iacoponi F; Rigante D; Brambilla G; Penco S; Brizi MG; Patrosso MC; Valesini G; Frediani B; Galeazzi M; Cimaz R; Paolazzi G; Vitale A; Imazio M Clin Res Cardiol; 2012 Jul; 101(7):525-31. PubMed ID: 22311714 [TBL] [Abstract][Full Text] [Related]
16. [Tumor necrosis receptor associated periodic syndrome (TRAPS): State of the art]. Georgin-Lavialle S; Kone-Paut I; Delaleu J; Sarrabay G; Grateau G; Touitou I; Hentgen V Rev Med Interne; 2018 Apr; 39(4):256-264. PubMed ID: 29525418 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic variability in two patients with tumor necrosis factor receptor associated periodic fever syndrome emphasizes a rare manifestation: Immunoglobulin A nephropathy. Balci S; Kisla Ekinci RM; Melek E; Atmis B; Bisgin A; Yilmaz M Eur J Med Genet; 2020 Apr; 63(4):103780. PubMed ID: 31586650 [TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review. Delaleu J; Deshayes S; Rodrigues F; Savey L; Rivière E; Silva NM; Aouba A; Amselem S; Rabant M; Grateau G; Giurgea I; Georgin-Lavialle S Rheumatology (Oxford); 2021 Dec; 60(12):5775-5784. PubMed ID: 33715002 [TBL] [Abstract][Full Text] [Related]
19. Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). La Torre F; Muratore M; Vitale A; Moramarco F; Quarta L; Cantarini L Rheumatol Int; 2015 Nov; 35(11):1943-7. PubMed ID: 26048626 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Aganna E; Hammond L; Hawkins PN; Aldea A; McKee SA; van Amstel HK; Mischung C; Kusuhara K; Saulsbury FT; Lachmann HJ; Bybee A; McDermott EM; La Regina M; Arostegui JI; Campistol JM; Worthington S; High KP; Molloy MG; Baker N; Bidwell JL; Castañer JL; Whiteford ML; Janssens-Korpola PL; Manna R; Powell RJ; Woo P; Solis P; Minden K; Frenkel J; Yagüe J; Mirakian RM; Hitman GA; McDermott MF Arthritis Rheum; 2003 Sep; 48(9):2632-44. PubMed ID: 13130484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]